06.02.2014 Views

Congress Abstracts - Society for Developmental Biology

Congress Abstracts - Society for Developmental Biology

Congress Abstracts - Society for Developmental Biology

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

development is already unknown. Embryos of 8.5-18.5 days post coitum (dpc) were obtained from pregnant mice -CD1 strain- 2<br />

postnatal days (dpn) mice were also evaluated; atrium and ventricles were dissected and studied separately. Reverse transcriptase PCR<br />

was per<strong>for</strong>med to analyze the expression of mRNA of AR, Nppa and Myh6; beta actin was used as endogenous control. The presence<br />

of the protein was evaluated by immunohistochemistry. Results: The mRNA and the protein of AR were expressed from 12.5 dpc to 2<br />

dpn mice. The AR mRNA is differentially expressed in atrium and ventricles at 16.5 dpc, 18.5 dpc and 2 dpn mice with the highest<br />

expression in atrial tissue. The expression of mRNA of Nppa and Myh6 displayed a similar pattern with prevalence in atria. These<br />

results indicate that androgen receptor could have a role in the functional differentiation of cardiomyocytes. Also, the differential<br />

expression between atria and ventricle suggest that androgen receptor could be involved in the physiology and development of atria.<br />

Partly supported by PAPIIT IN226811<br />

Program/Abstract # 371<br />

Withdrawn<br />

Program/Abstract # 372<br />

A heterogeneous cellular origin of the cardiac lymphatic vasculature.<br />

Klotz, Linda; Ruhrberg, Christiana (University College London, UK); Riley, Paul (University of Ox<strong>for</strong>d, UK)<br />

The lymphatic vasculature is a blind-ended network crucial <strong>for</strong> tissue fluid homeostasis, immune surveillance and lipid adsorption<br />

from the gut, as well as being the main route of cancer metastasis. The heart is the first organ to develop in mammals, however little is<br />

known about the lymphatic vasculature in the heart. The mechanisms regulating the development of the cardiac lymphatic vessels, as<br />

well as their cellular origin, are yet to be described. In this study we shed light on the development and origin of the cardiac lymphatic<br />

vasculature from mid-gestation to early adulthood in mice. We show that lymphatic vessels first sprout at embryonic day 14.5 (E14.5)<br />

in the outflow region of the heart and develop alongside coronary blood vessels, completing development and largely encompassing<br />

the heart by postnatal day 15 (P15). We have utilized various Cre transgenic mouse lines to give a comprehensive overview of lineage<br />

contributions to the cardiac lymphatic vessels. Contrary to the current dogma of the field suggesting that veins give rise to the entire<br />

lymphatic network, our lineage tracing analyses suggest a heterogeneous cellular origin <strong>for</strong> developmental de novo<br />

lymphvasculogenesis in the heart – with the involvement of both blood endothelial as well as other lineages. O ur characterization of<br />

the cardiac lymphatic vasculature offers novel insight into a largely overlooked, but arguably very important part of the lymphatic<br />

system. Future studies will focus on applying the findings from lymphatic development in the embryonic heart to adult cardiovascular<br />

pathology and disease.<br />

Program/Abstract # 373<br />

Elucidation of the molecular mechanism of Rasip1 and Arhgap29 in blood vessel development.<br />

Koo, Yeon (Univ of Texas Southwestern Med Ctr, USA), Xu, Ke (Harvard, USA); Davis, George (Univ. of Missouri, United States);<br />

Cleaver, Ondine (Univ of Texas Southwestern Med Ctr, USA)<br />

Cardiovascular function depends on patent, continuous blood vessel <strong>for</strong>mation by endothelial cells (ECs). Blood vessel development<br />

initiates during ‘vasculogenesis’ via the aggregation of ECs into linear aggregates, which then <strong>for</strong>m tubes with a central lumen that<br />

allows blood flow. However the mechanisms underlying vascular ‘tubulogenesis’ are only beginning to be unraveled. We recently<br />

showed that a novel GTPase-interacting protein called Rasip1 and its binding partner the RhoGAP Arhgap29 are required <strong>for</strong><br />

<strong>for</strong>mation of continuous blood vessel lumens. Rasip1 null embryos showed disrupted localization of EC polarity and junctional<br />

complexes, and loss of adhesion of ECs to extracellular matrix (ECM). In vitro studies also showed that depletion of either Rasip1 or<br />

Arhgap29 in cultured ECs lead to failed tubulogenesis and abrogation of integrin-dependent adhesion contact maturation. From these<br />

studies, we propose that Rasip1 and Arhgap29 regulate multiple cellular processes required <strong>for</strong> functional vascular tubulogenesis.<br />

Program/Abstract # 374<br />

Annexin A3 is required <strong>for</strong> early blood vessel <strong>for</strong>mation<br />

Meadows, Stryder M.; Fletcher, Peter (UT Southwestern Medical Center, USA); Sacharidou, Anastasia; Davis, George (University of<br />

Missouri, USA); Cleaver, Ondine (UT Southwestern Medical Center, USA)<br />

Annexins are a unique class of proteins that bind to membrane phospholipids in a calcium-dependent manner. They are able to<br />

function in several different capacities that include organizing membrane domains and cytoskeletal linkages, as well as regulating both<br />

exocytic and endocytic transport and the flow of ions across cell membranes. While annexins are linked to many cellular processes,<br />

the function of Annexin A3 (Anxa3) during development is completely unknown. Our studies show that Anxa3 expression is<br />

conserved in the endothelial cell (EC) lineage of mice, frogs and fish, suggesting an important role during vascular development.<br />

Morpholino (MO) studies demonstrate an essential requirement <strong>for</strong> Anxa3 during early blood vessel <strong>for</strong>mation, as Anxa3 MO-treated<br />

Xenopus embryos lack the tight junction molecule Claudin-5 and exhibit severe disruptions in EC-EC adhesion and failure of vascular<br />

cord <strong>for</strong>mation. Furthermore, Anxa3 siRNA-treated ECs fail to assemble into vessel-like networks in 3D collagen matrices in vitro,<br />

suggesting adhesion defects. Overall, these studies demonstrate a requirement <strong>for</strong> Anxa3 in assembly and coalescence of ECs, and are<br />

the first to indicate a role <strong>for</strong> Anxa3 during vascular development.<br />

107

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!